Costa Rica vs Montenegro: Share of the population living with HIV receiving antiretroviral therapy
Costa Rica
61.6%
in 2024
Montenegro
61.0%
in 2024
Costa Rica rank
105th
Montenegro rank
108th
Share of the population living with HIV receiving antiretroviral therapy over time
- Costa Rica
- Montenegro
How they compare
Costa Rica currently reports 61.6% against 61.0% in Montenegro, a difference of 0.6%.
The two have swapped places 5 times across 35 shared years of data; in 1990 it was Montenegro ahead.
Costa Rica ranks 105th and Montenegro ranks 108th of 149 countries.
Across the 4 decades both report, Costa Rica averaged higher in 3 and Montenegro in 1.
Head to head by decade
| Decade | Costa Rica | Montenegro | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0.0% | 0.4% | 0.4% | Montenegro |
| 2000s | 18.5% | 17.0% | 1.6% | Costa Rica |
| 2010s | 41.2% | 36.8% | 4.4% | Costa Rica |
| 2020s | 59.2% | 55.3% | 3.9% | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of the population living with hiv receiving antiretroviral therapy, Costa Rica or Montenegro?
- Costa Rica, at 61.6% against 61.0% in Montenegro as of 2024.
- What is the difference in share of the population living with hiv receiving antiretroviral therapy between Costa Rica and Montenegro?
- 0.6%, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Montenegro?
- 35 years are reported by both, from 1990 to 2024.
- How do Costa Rica and Montenegro rank globally for share of the population living with hiv receiving antiretroviral therapy?
- Costa Rica ranks 105th and Montenegro ranks 108th of 149 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as Share of the population living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of individuals diagnosed with HIV who are currently receiving antiretroviral therapy. This is the central estimate.